
This randomized clinical trial compared the safety and effectiveness of personalized Indocyanine-guided pelvic lymph node dissection (PLND) with extended PLND (ePLND) during radical prostatectomy. The study included 108 patients with intermediate or high-risk prostate cancer. The results showed that the postoperative complication rate was significantly lower in the Indocyanine-guided PLND group (32%) compared to the ePLND group (70%). There were no significant differences in major complications or oncological outcomes such as pN1 detection, undetectable PSA levels, or biochemical recurrence-free survival. The personalized Indocyanine-guided PLND technique appears promising for accurately staging intermediate and high-risk prostate cancer patients with fewer complications than ePLND in the short term.
Like
Save
Share